Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Moves Into New Expanded Facility

NEW YORK, Sept. 28 (GenomeWeb News) - US Genomics, a Woburn, Mass.-based biotech company, has expanded its operations into a new 34,000-square-foot, custom-built facility in Woburn.


The company said that the move was partially to accomodate to the launch of its first commercial product, the Trilogy platform, for detecting minute quantities of DNA, RNA, and proteins without amplification.


The move also coincides with the commencement of a $7.5 million grant recently awarded to the company by the US Department of Homeland Security to develop a pathogen sensor based on its direct linear DNA-mapping technology.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.